27 Oct 2023
iPROLEPSIS project and iPROLEPSIS-PDPID study presented at the 15th Portuguese Rheumatology Congress
On October 27, 2023, the Portuguese Society of Rheumatology (SPR), a dedicated partner of iPROLEPSIS, took the stage at the 15th Portuguese Rheumatology Congress (XXV Congresso Português de Reumatologia), the event attended by around 700 individuals, mainly rheumatologists and GPs.
Cátia Gonçalves, Reuma.pt Study Coordinator, and Ana M. Rodrigues, Reuma.pt National Coordinator and Assistant Professor at NOVA Medical School, provided a comprehensive overview of the iPROLEPSIS project, its goals, and clinical studies. They also introduced the iPROLEPSIS-PDPID study, focusing on PsA digital phenotyping and inflammation drivers.
Portuguese Rheumatology centres were invited to participate in the iPROLEPSIS-PDPID study, marking a significant step in advancing our research.